@article{c792fd04e9704f7bb500b436d456a025,
title = "Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia",
abstract = "LBH589 is a novel cinnamic hydroxamic acid analog (HAA) pan-histone deacetylase inhibitor (HDACi) currently in early phase clinical development.",
author = "Anna Kalff and Jake Shortt and J Farr and Roger McLennan and A Lui and Scott, \{Jeffrey W\} and Andrew Spencer",
year = "2008",
doi = "10.3324/haematol.11933",
language = "English",
volume = "93",
pages = "16 -- 17",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Fondazione Ferrata Storti",
number = "1",
}